Novartis Is “On A Mission” To Address Unmet Hypertension Needs
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis is targeting the 30 mil.-35 mil. untreated hypertension patients in the U.S. and is relaunching a compliance program to target existing patients.